ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
Status:
Terminated
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
Adenocorticotrophic Hormone provides safe and effective treatment to induce disease remission
in rheumatoid arthritis patients with active disease due to an inadequate response to
methotrexate.